52w high/low | ₹1918.75 / ₹1376 |
P/E ratio | 61.33 |
Dividend | 1.32 |
ROE | 47.52 |
ROCE | 63.86 |
Face value | 10 |
Book value | ₹98.85Cr |
Market capital | ₹41,031.84Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc, UK, one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer and others. They have two manufacturing units in India, located at Nashik and Thane. Also, they have a clinical development centre in Bangalore. GlaxoSmithKline Pharma Ltd was incorporated in the year 1927.